Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says ⊕
found
⊕ Slightly Positive overall
0.00 negativity
0.94 neutrality
0.06 positivity
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.